FEB 25, 2019 10:58 AM PST

A Signal That Acts as an Interspecies Messenger is Revealed

WRITTEN BY: Carmen Leitch

The massive community of microbes that lives in our gastrointestinal tract, the gut microbiome, plays important physiological roles. It helps us digest food and absorb nutrients, and is closely related to our immune system. All of those bacteria are also carrying around their own genomes, and researchers are finding that the bacterial genes with them can have a significant effect on human health. New work reported in Cell has outlined a type of signal between bacteria and their host - an interspecies communication in which nitric oxide released by the bacteria can impact their hosts' DNA. 

Jonathan Stamler, M.D. / Credit: Case Western Reserve University School of Medicine

"There is tremendous complexity in the gut, and many researchers are after the next unusual substance produced by a bacterium that might affect human health," said the senior author of the study Jonathan Stamler, MD, director of the Institute for Transformative Molecular Medicine at Case Western Reserve University School of Medicine. Stamler wanted to find a common thread of communication that could be used by all the trillions of bacteria in the gut. "The enormity of the gut bacteria population and its relationship to the host predicts there will be general means to communicate that we humans can recognize."

In this work, the research team tracked the secretion of nitric oxide by gut bacteria that resides in C. elegans, a worm that is a common molecular research model. The bacterially-secreted nitric oxide was bound to thousands of worm host proteins. It changed the way the worm genes were being regulated.

This study is the first time scientists have shown that gut bacteria can affect mammalian nitric oxide pathways. In a precisely controlled and reversible process called S-nitrosylation, nitric oxide is added to proteins, and is a post-translational regulator of protein function. Dysfunction in S-nitrosylation has been implicated in many human diseases including cancer, asthma, heart disease, and others.

The worms in this study were fed bacteria that make nitric oxide. The scientists focused on a critical protein that regulates genes, called ALG-1, and found that when the bacterially-derived nitric oxide attached to the ALG-1, the developing organs in the worm became malformed and they died. The overload of bacterial nitric oxide ruined healthy development by controlling the worms’ DNA.

"Practically, animals will not let this happen," Stamler said. The authors suggest that outside of the lab, a mammalian host would adjust to accommodate varying nitric oxide levels. "The worm is going to be able to stop eating the bacteria that make the nitric oxide, or it will begin to eat different bacteria that makes less nitric oxide, or change its environment, or countless other adaptations. But by the same token, too much nitric oxide produced by our microbiome may cause disease or developmental problems in the fetus,” explained Stamler.

Stamler wants to pursue this work and determined whether nitric oxide can be useful in the manipulation of the microbiome for therapeutic purposes.

"I now think of this therapeutically, as a drug,” he said. “There are tremendous opportunities to manipulate nitric oxide to improve human health."

This probably only the first of many such interspecies signaling molecules to be found. “We're basically seeing a new field opening for general strategies of communication," said Stamler. "There will be others."

Learn more about how manipulation of the gut microbiome might help us treat disease fromthe video.


Sources: AAAS/Eurekalert! via Case Western Reserve University, Cell

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 06, 2020
Drug Discovery & Development
JAN 06, 2020
Designing Drugs To Fight off C. Diff Infections
A study published by PNAS explains breakthrough research around designing drugs that target C. diff bacterial infections that result in 15,000 deaths in th...
JAN 08, 2020
Microbiology
JAN 08, 2020
Researchers Discover Many New Viruses That are Carried by Insects
Zoonotic diseases are caused by infectious microorganisms like bacteria or viruses, and are passed between animals, including humans....
FEB 12, 2020
Drug Discovery & Development
FEB 12, 2020
Does Traditional Chinese Medicine Work Against Coronavirus?
Over 45,000 cases of Wuhan Coronavirus have been reported globally, alongside over 1,100 deaths. Although over 4,700 people are said to have recovered from...
MAR 02, 2020
Cancer
MAR 02, 2020
E. coli and colon cancer
Research published recently in Nature provides evidence for a direct link between the presence of E. coli and increased risk of colon cancer. Res...
MAR 03, 2020
Drug Discovery & Development
MAR 03, 2020
Drug Used for Ebola Virus Could Fight COVID19
Previously, the drug remdesivir was found to treat coronaviruses that cause Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (...
MAR 25, 2020
Clinical & Molecular DX
MAR 25, 2020
A coronavirus testing kit with glow-in-the-dark Mango?
A group of Canadian researchers is responding to a desperate need for COVID-19 diagnostic kits with their fluorescent imaging technology, known as Mango. M...
Loading Comments...